14 research outputs found
Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma : A Review
It is well recognized that the presence of cervical lymph node metastasis is the most important prognostic factor in oral squamous cell carcinoma (OSCC). In solid epithelial cancer, the first step during the process of metastasis is the invasion of cancer cells into the underlying stroma, breaching the basement membrane (BM)βthe natural barrier between epithelium and the underlying extracellular matrix (ECM). The ability to invade and metastasize is a key hallmark of cancer progression, and the most complicated and least understood. These topics continue to be very active fields of cancer research. A number of processes, factors, and signaling pathways are involved in regulating invasion and metastasis. However, appropriate clinical trials for anti-cancer drugs targeting the invasion of OSCC are incomplete. In this review, we summarize the recent progress on invasion-related factors and emerging molecular determinants which can be used as potential for diagnostic and therapeutic targets in OSCC
Periostin Promotes Tumor Lymphangiogenesis
Background: Metastasis to regional lymph nodes via lymphatic vessels plays a key role in cancer progression. Tumor lymphangiogenesis is known to promote lymphatic metastasis, and vascular endothelial growth factor C (VEGF-C) is a critical activator of tumor lymphangiogenesis during the process of metastasis. We previously identified periostin as an invasion- and angiogenesis-promoting factor in head and neck squamous cell carcinoma (HNSCC). In this study, we discovered a novel role for periostin in tumor lymphangiogenesis.
Methods and Findings: Periostin overexpression upregulated VEGF-C mRNA expression in HNSCC cells. By using conditioned media from periostin-overexpressing HNSCC cells, we examined tube formation of lymphatic endothelial cells. Conditioned media from periostin-overexpressing cells promoted tube formation. To know the correlation between periostin and VEGF-C, we compared Periostin expression with VEGF-C expression in 54 HNSCC cases by immunohistochemistry. Periostin expression was correlated well with VEGF-C expression in HNSCC cases. Moreover, correlation between periostin and VEGF-C secretion was observed in serum from HNSCC patients. Interestingly, periostin itself promoted tube formation of lymphatic endothelial cells independently of VEGF-C. Periostin-promoted lymphangiogenesis was mediated by Src and Akt activity. Indeed possible correlation between periostin and lymphatic status in periostin-overexpressing xenograft tumors and HNSCC cases was observed.
Conclusions: Our findings suggest that periostin itself as well as periostin-induced upregulation of VEGF-C may promote lymphangiogenesis. We suggest that periostin may be a marker for prediction of malignant behaviors in HNSCC and a potential target for future therapeutic intervention to obstruct tumoral lymphatic invasion and lymphangiogenesis in HNSCC patients
MMP-13 Promotes Tumor Angiogenesis
Background: Angiogenesis is an important step in the metastatic cascade of tumors.
Results: MMP-13 itself as well as VEGF-A secretion from fibroblasts promotes angiogenesis. Indeed, MMP-13 is well correlated with blood vessel density in human cancer tissues.
Conclusion: MMP-13 can be a marker for prediction of malignant behaviors and a therapeutic target in cancer.
Significance: This work provides new insights regarding the role of MMP-13 in tumor angiogenesis
MMP-10/Stromelysin-2 Promotes Invasion of Head and Neck Cancer
Background: Periostin, IFN-induced transmembrane protein 1 (IFITM1) and Wingless-type MMTV integration site family, member 5B (Wnt-5b) were previously identified as the invasion promoted genes of head and neck squamous cell carcinoma(HNSCC) by comparing the gene expression profiles between parent and a highly invasive clone. We have previously reported that Periostin and IFITM1 promoted the invasion of HNSCC cells. Here we demonstrated that Wnt-5b overexpression promoted the invasion of HNSCC cells. Moreover, stromelysin-2 (matrix metalloproteinase-10; MMP-10) was
identified as a common up-regulated gene among Periostin, IFITM1 and Wnt-5b overexpressing HNSCC cells by using
microarray data sets. In this study, we investigated the roles of MMP-10 in the invasion of HNSCC.
Methods and Findings: We examined the expression of MMP-10 in HNSCC cases by immunohistochemistry. High expression of MMP-10 was frequently observed and was significantly correlated with the invasiveness and metastasis in HNSCC cases. Next, we examined the roles of MMP-10 in the invasion of HNSCC cells in vitro. Ectopic overexpression of
MMP-10 promoted the invasion of HNSCC cells, and knockdown of MMP-10 suppressed the invasion of HNSCC cells.
Moreover, MMP-10 knockdown suppressed Periostin and Wnt-5b-promoted invasion. Interestingly, MMP-10 overexpression
induced the decreased p38 activity and MMP-10 knockdown induced the increased p38 activity. In addition, treatment with a p38 inhibitor SB203580 in HNSCC cells inhibited the invasion.
Conclusions: These results suggest that MMP-10 plays an important role in the invasion and metastasis of HNSCC, and that invasion driven by MMP-10 is partially associated with p38 MAPK inhibition. We suggest that MMP-10 can be used as a marker for prediction of metastasis in HNSCC
Periostin Directly and Indirectly Promotes Tumor Lymphangiogenesis of Head and Neck Cancer
Periostin Directly and Indirectly Promotes Tumor Lymphangiogenesis of Head and Neck Cancer
<div><h3>Background</h3><p>Metastasis to regional lymph nodes via lymphatic vessels plays a key role in cancer progression. Tumor lymphangiogenesis is known to promote lymphatic metastasis, and vascular endothelial growth factor C (VEGF-C) is a critical activator of tumor lymphangiogenesis during the process of metastasis. We previously identified periostin as an invasion- and angiogenesis-promoting factor in head and neck squamous cell carcinoma (HNSCC). In this study, we discovered a novel role for periostin in tumor lymphangiogenesis.</p> <h3>Methods and Findings</h3><p>Periostin overexpression upregulated VEGF-C mRNA expression in HNSCC cells. By using conditioned media from periostin-overexpressing HNSCC cells, we examined tube formation of lymphatic endothelial cells. Conditioned media from periostin-overexpressing cells promoted tube formation. To know the correlation between periostin and VEGF-C, we compared Periostin expression with VEGF-C expression in 54 HNSCC cases by immunohistochemistry. Periostin expression was correlated well with VEGF-C expression in HNSCC cases. Moreover, correlation between periostin and VEGF-C secretion was observed in serum from HNSCC patients. Interestingly, periostin itself promoted tube formation of lymphatic endothelial cells independently of VEGF-C. Periostin-promoted lymphangiogenesis was mediated by Src and Akt activity. Indeed possible correlation between periostin and lymphatic status in periostin-overexpressing xenograft tumors and HNSCC cases was observed.</p> <h3>Conclusions</h3><p>Our findings suggest that periostin itself as well as periostin-induced upregulation of VEGF-C may promote lymphangiogenesis. We suggest that periostin may be a marker for prediction of malignant behaviors in HNSCC and a potential target for future therapeutic intervention to obstruct tumoral lymphatic invasion and lymphangiogenesis in HNSCC patients.</p> </div
Periostin promotes lymphangiogenesis in vivo.
<p>(A) Periostin-overexpressing (periostin) and empty vector-transfected (control) HSC2 cells (1Γ10<sup>7</sup> cells) were individually injected subcutaneously at 2 sites in each of 5 nude mice. After 1 month, the tumors were resected and stained with an anti-mouse LYVE-1 antibody recognising lymphatic vessels. Representative cases of immunohistochemical staining for LYVE-1 in control and periostin-overexpressing tumors are shown. Arrow shows LYVE-1 positive lymphatic vessels. (B) The LYVE-1 positive lymphatic vessels in control and periostin-overexpressing tumors were counted. The graph shows the average numbers of lymphatic vessels in control and periostin-overexpressing tumors. The bars show the average values and SDs.</p
Correlation between periostin and VEGF-C in HNSCC.
<p>(A) Immunohistochemical staining for periostin and VEGF-C in HNSCC cases. Representative HNSCC cases (high and low magnification) with periostin and VEGF-C expression are shown. Scale bar is shown in each picture. (B) Graph shows the VEGF-C expression status in HNSCC cases with high or low expression of periostin. (C) Serum level of periostin and VEGF-C in 81 HNSCC patients was examined by ELISA. Serum level of periostin and VEGF-C was compared with tumor stage. Graph shows percentage of periostin or VEGF-C positive cases in different tumor stage (from stage 1 to 4). (D) Serum level of periostin and VEGF-C was compared with lymph node metastasis. Graph shows percentage of periostin or VEGF-C positive cases in cases with or without lymph node metastasis (E) Serum level of periostin was compared with serum level of VEGF-C. Graph shows percentage of VEGF-C positive cases in cases with periostin positive or negative.</p
Correlation between periostin expression and lymphatic status in clinical HNSCC cases.
<p>(A) Periostin and D2-40 expression levels were examined by immunohistochemical staining of HNSCC case specimens. A representative case of periostin and D2-40 expression in HNSCC is shown. Arrow shows D2-40 positive lymphatic vessels. (B) The graph shows the comparison between the average numbers of lymph vessels in intratumoral, peritumoral, and total areas in HNSCC cases with high or low expression of periostin. (C) The graph shows the status of lymphatic invasion in HNSCC cases with high or low expression of periostin.</p